TELO: 1.77M Shares Reported by John Paul DeJoria, Sole Voting Control

Rhea-AI Filing Summary

John Paul DeJoria, both personally and as trustee of the John Paul DeJoria Family Trust, reports beneficial ownership of 1,774,900 shares of Telomir Pharmaceuticals, Inc. common stock, representing 5.50% of the outstanding class. The filing indicates Mr. DeJoria has sole voting and dispositive power over these shares and states the shares were not acquired to change or influence control of the company. The filing lists the issuer's principal office in Miami, FL, and provides a business address for the reporting person in Georgetown, TX. A power of attorney is attached as an exhibit.

Positive

• Ownership disclosed above 5%, providing transparency to the market about a significant stakeholder
• Sole voting and dispositive power simplifies clarity on who controls voting for the reported shares
• Certification denies intent to influence control, reducing immediate governance disruption risk

Negative

• Concentrated ownership (5.50%) gives a single individual meaningful voting influence which could affect corporate actions
• No transaction history or acquisition details are provided, limiting visibility into how or when the stake was built

Insights

Financial Analyst

TL;DR: A notable individual investor holds 5.5% of TELO with full voting and disposal authority, a position investors should register but which the filer says is non-control.

The reported 1,774,900-share stake equals 5.50% of the class, which crosses the common-reporting threshold and may increase market attention. The statement that the shares were not acquired to influence control reduces likelihood of an immediate activist push. Sole voting and dispositive power concentrates influence in the reporting person, which could matter for proxy matters or corporate actions. No purchases, transactions, or changes in intent are documented in the filing text provided.

Corporate Governance Expert

TL;DR: Ownership above 5% with sole voting power is material for governance monitoring though the filer disclaims control intent.

The filing is clear that the reporting person holds both sole voting and sole dispositive authority for the entire stake, which means this individual can vote those shares unilaterally. The certification denies acquisition for control purposes, suggesting no immediate governance campaign. For boards and governance officers, this ownership level warrants monitoring for future disclosures, proxy solicitations, or changes in intentions, but the document itself shows no activist plans or additional arrangements.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Telomir Pharmaceuticals, Inc.

(Name of Issuer)

Common Stock, no par value

(Title of Class of Securities)

87975F104

(CUSIP Number)

09/09/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 87975F104

1

Names of Reporting Persons

John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 1,774,900.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 1,774,900.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,774,900.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.50 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Telomir Pharmaceuticals, Inc.
(b)	Address of issuer's principal executive offices: 100 SE 2nd Street Suite 2000 #1009 Miami, FL, 33131
Item 2.
(a)	Name of person filing: John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity
(b)	Address or principal business office or, if none, residence: The business address of Mr. DeJoria is 109 West 7th Street, Suite 200, Georgetown, Texas 78626
(c)	Citizenship: United States
(d)	Title of class of securities: Common Stock, no par value
(e)	CUSIP No.: 87975F104
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 1,774,900
(b)	Percent of class: 5.50%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 1,774,900
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 1,774,900
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity

Signature:	/s/ Matthew R. Bair
Name/Title:	Matthew R. Bair, Attorney-in-Fact
Date:	09/18/2025

Exhibit Information

EXHIBIT 24.1 Power of Attorney for John Paul DeJoria

FAQ

What stake in Telomir Pharmaceuticals (TELO) does John Paul DeJoria report?

The filing reports a beneficial ownership of 1,774,900 shares, equal to 5.50% of the class.

Does the reporting person have voting control over the TELO shares?

Yes. The filing shows sole voting power and sole dispositive power over all 1,774,900 shares.

Was the stake reported as intended to influence control of TELO?

No. The certification states the securities were not acquired to change or influence control of the issuer.

Are there any group affiliations or shared ownership reported?

No. The filing indicates no shared voting or dispositive power and lists no group members.

What supporting documentation is attached to the filing?

The filing references Exhibit 24.1, a Power of Attorney for John Paul DeJoria.